Source file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.931
PT TAISHO PHARMACEUTICAL INDONESIA TBK. Head Office: Millennium Centennial Center 8" fl, Jl. Jend. Sudirman Kav. 25, Jakarta 12920, INDONESIA Phone: #62 21 3970 6720, Fax: #62 21 3972 6735 Technical Operations: Jl. Raya Jakarta-Bogor Km. 38, Cilangkap, Tapos (Depok) 16458, INDONESIA Phone: #62 21 875 2583 /875 2584, Fax: 462 21 875 2585 PT TAISHO PHARMACEUTICAL INDONESIA Tbk SURAT PERNYATAAN DEWAN DIREKSI TENTANG TANGGUNG JAWAB ATAS LAPORAN KEUANGAN UNTUK TAHUN YANG BERAKHIR PADA PT TAISHO PHARMACEUTICAL INDONESIA Tbk BOARD OF DIRECTORS' STATEMENT REGARDING THE RESPONSIBILITY FOR THE FINANCIAL STATEMENTS FOR THE YEAR THEN ENDED OF 31 DESEMBER 2023 Kami, yang bertanda tangan di bawah ini: 1. Nama Alamat kantor Alamat domisili atau sesuai KTP Nomor telepon Jabatan Nama Alamat kantor Alamat domisili atau sesuai KTP Nomor telepon Jabatan Yukio Sawada Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 #021-3970 6720 Direktur /Director Budhy Herwindo Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 “4021-3970 6720 Direktur /Director DECEMBER 31, 2023 We, the undersigned below: Name Office address Domicile address or address according to ID Telephone number Title Name Office address Domicile address or address according to ID Telephone number Title menyatakan bahwa: 1. Kami bertanggung jawab atas penyusunan dan penyajian laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk, 2. Laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk telah disusun dan disajikan sesuai dengan Standar Akuntansi Keuangan di Indonesia, 3. a. Semua informasi dalam laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk telah dimuat secara lengkap dan benar, dan b. Laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk tidak mengandung informasi atau fakta material yang tidak benar, dan tidak menghilangkan informasi atau fakta material, . The financial declare that: . We are responsible for the preparation and presentation of the financial statements of PT Taisho Pharmaceutical Indonesia Tbk, statemenits of PT Taisho Pharmaceutical Indonesia Tbk have been prepared and presented in accordance with Indonesian Financial Accounting Standards, ..a. All information in the financial statements of PT Taisho Pharmaceutical Indonesia Tbk have been fully disclosed in a complete and truthful manner, and b. The financial statements of PT Taisho Pharmaceutical Indonesia Tbk do not contain any incorrect information or material fact, nor do they omit any information or material fact:
Page 2 OCR 0.826
(&) PT TAISHO PHARMACEUTICAL INDONESIA TBK. Head Office: Millennium Centennial Center 8" H1, Jl. Jend. Sudirman Kav. 25, Jakarta 12920, INDONESIA Phone: #62 21 3970 6720, Fax: #62 21 3972 6735 Technical Operations: Jl. Raya Jakarta-Bogor Km. 38, Cilangkap, Tapos (Depok) 16458, INDONESIA Phone: #62 21 875 2583 /875 2584, Fax: 462 21 875 2585 4. Kami bertanggung jawab atas sistem pengendalian — 4. We are responsible for the internal control system internal — dalam PT Taisho — Pharmaceutical of PT Taisho Pharmaceutical Indonesia Tbk. Indonesia Tbk. Demikian pernyataan ini dibuat dengan sebenarnya. This statement is made truthfully. Jakarta, 27 Maret 2024/ Jakarta, March 27, 2024 H4 F Ti AL 2 Mn 4 w Ea BOAKX841827482 . Yukio Sawada Budhy Herwindo Direksi/Director Direksi/Director
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
unresolved
org
TAISHO PHARMACEUTICAL INDONESIA TBK.
p.1 ×26
unresolved
org
PT Taisho
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.
Other files in this announcement 7
FinancialStatement-2023-Tahunan-SQBB.xlsx
done
LK 31122023.pdf
done
inlineXBRL.zip
done
instance.zip
done